Simpson Thacher Represents Wells Fargo in $2.75 Billion Revolving Credit Agreement for Boston Scientific
01.02.19
This is only gets display when printing
The Firm recently represented Wells Fargo Bank, National Association in connection with Boston Scientific’s $2.75 billion revolving credit agreement.
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. Boston Scientific Corporation’s products and technologies are used to diagnose or treat a wide range of medical conditions, including cardiovascular, digestive, respiratory, urological, pelvic health and neurological conditions.
The Simpson Thacher team includes Jessica Tuchinsky, Mike Vernace and David Acquay (Banking & Credit); and Morgan Otway (Tax).